PTIX logo

Protagenic Therapeutics, Inc. Stock Price

NasdaqCM:PTIX Community·US$3.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PTIX Share Price Performance

US$2.06
-9.04 (-81.44%)
US$2.06
-9.04 (-81.44%)
Price US$2.06

PTIX Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Protagenic Therapeutics, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$0

Other Expenses

US$0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About PTIX

Founded
2004
Employees
n/a
CEO
n/a
WebsiteView website
phytanix.com

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Recent PTIX News & Updates

Recent updates

No updates